<DOC>
	<DOCNO>NCT02458248</DOCNO>
	<brief_summary>Chronic kidney disease , affect estimate 300,000 people Ireland 50 million people developed world , responsible considerable burden premature mortality morbidity . All patient chronic kidney disease recommend low salt diet , i.e . le teaspoon salt per day ( &lt; 5-6g salt , contain &lt; 2-2.3g sodium ) . The average intake general population double recommend intake , 1-2 teaspoon per day , consider 'moderate ' intake . In patient hypertension , reduce moderate ( average ) low intake associate small reduction blood pressure . However , achieve low target salt intake difficult , negative knock-on effect healthy dietary factor kidney hormone . In addition , convince research show patient chronic kidney disease normal blood pressure benefit low salt intake . In fact , small amount research exist show change kidney function people consume low salt diet ( &lt; 1 teaspoon ) moderate ( 1-2 teaspoons=average intake ) salt diet . Moreover , small study report low-salt diet may increase risk death due heart disease . Given patient chronic kidney impairment recommend low-salt diet , important confirm recommendation truly benefit patient . In randomized controlled trial , hope determine whether recommend low salt intake , compare average/moderate intake , associate slow rate decline kidney function patient chronic kidney impairment . The result study provide information guide future research critical implication management patient chronic kidney disease .</brief_summary>
	<brief_title>Sodium Intake Chronic Kidney Disease ( STICK )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Age 40 year old MDRD eGFR 3060ml/min/1.73m2 ≥2 occasion ≥3 month apart Most recent eGFR measurement within 3 month Systolic blood pressure &lt; 160mmHg diastolic blood pressure &lt; 95mmHg three office blood pressure reading time screen confirm study ABPM randomisation &lt; 150/90mmHg No change antihypertensive diuretic medication ( include dose ) 3 month screen visit Consumption moderate sodium intake screening , define estimate daily sodium intake &gt; 2.3g/day estimate food frequency questionnaire ( FFQ ) complete screen visit Selfreported willingness modify dietary intake sustain period , adhere direct recommendation 2 year Signed write informed consent Acute Kidney Injury precede three month , define double baseline serum creatinine rapidly decline eGFR precede six month , define decline eGFR ≥10ml/min/1.73m2 establish CKD Any follow renal condition : glomerular disease due postinfectious glomerulonephritis , IgA nephropathy , thin basement membrane disease , HenochSchonlein purpura , proliferative glomerulonephritis , membranous nephropathy ( include lupus nephritis ) , rapidly progressive glomerulonephritis , minimal change disease , focal segmental glomerulosclerosis Prior plan renal transplantation Prior , current plan renal dialysis Medical diagnosis know associate abnormal renal sodium excretion , include Bartter syndrome , SIADH , diabetes insipidus , serum sodium &lt; 125mmol Severe heart failure ( define leave ventricular ejection fraction ≤30 % NYHA Class III/IV symptom ) Highdose loop thiazide diuretic therapy , exceed total daily dose frusemide 80mg , bumetanide 2mg , hydrochlorothiazide 50mg , bendroflumethiazide 2.5mg , indapamide 2.5mg , metolazone 2.5mg use loop thiazide diuretic Current use nonsteroidal antiinflammatory drug ( NSAIDs ) 3 day per week . Lowdose aspirin &lt; 100mg/day exclusion Unable follow educational advice research team Prescribed highsalt diet , lowsalt diet sodium bicarbonate Symptomatic postural hypotension receive treatment postural hypotension Current recent use ( within one month ) immunosuppressive medication include tacrolimus , cyclosporine , azathioprine mycophenolate mofetil Pregnancy lactation Unable comply 24hour urinary collection , medical condition make collection 24hour urinary collection difficult ( e.g . severe urinary incontinence ) Participant unlikely comply study procedure followup visit due severe comorbid illness factor ( e.g . inability travel followup visit , drug alcohol misuse ) opinion research team Cognitive impairment define know diagnosis dementia , inability provide inform consent due cognitive impairment opinion investigator Body Mass Index ( BMI ) &lt; 20kg/m2 BMI &gt; 40kg/m2 Participating another clinical trial previous allocation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Sodium Reduction</keyword>
	<keyword>eGFR 30-60ml/min/1.73m2</keyword>
</DOC>